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In this work, we present a study of the interaction between human serum albumin (HSA) and acetylsalicylic acid (ASA, C9H8O4)
by molecular dynamics simulations (MD). Starting from an experimentally resolved structure of the complex, we performed the
extraction of the ligand by means of the application of an external force. After stabilization of the system, we quantified the force
used to remove the ASA from its specific site of binding to HSA and calculated the mechanical nonequilibrium external work
done during this process. We obtain a reasonable value for the upper boundary of the Gibbs free energy difference (an equilibrium
thermodynamic potential) between the complexed and noncomplexed states. To achieve this goal, we used the finite sampling
estimator of the average work, calculated from the Jarzynski Equality. To evaluate the effect of the solvent, we calculated the so-
called “viscous work,” that is, the work done to move the aspirin in the same trajectory through the solvent in absence of the
protein, so as to assess the relevance of its contribution to the total work. The results are in good agreement with the available
experimental data for the albumin affinity constant for aspirin, obtained through quenching fluorescence methods.
1. Introduction
Human serum albumin (HSA) is the most abundant plasma
protein in the human body and plays an important role
in drug transport and metabolism. Generally regarded as
a nonspecific transport protein, HSA has been assigned a
number of enzymatic properties [1–3]. Additionally, the
enzymatic activity of HSA on different substrates and drugs
has also been studied and documented. Nevertheless, the
structural mechanism of this activity is yet unknown.
To assess the structural basis of binding mechanisms, we
evaluated the interaction between HSA and acetylsalicylic
acid (ASA, C9H8O4) by means of molecular dynamics
simulations (MD).
Starting from an experimentally resolved structure of the
complex, we extracted the ligand by means of the application
of an external force, under near quasistatic conditions, thus
evaluating the work involved in breaking the interactions
present in the protein-ligand complex, and hence obtaining
an upper boundary for the free energy of binding of the
complex.
We quantified the force used to remove the ASA from its
specific site of binding to HSA and calculated the mechanical
nonequilibrium external work done during this process.
The aim of the present study is to calculate an upper
boundary for the Gibbs free energy difference associated to
that process, through the average work obtained using the
finite sampling estimator from the Jarzynski equality.
To evaluate the effect of the solvent (treated explicitly),
we calculated the “viscous work.” This magnitude represents
the work done to move the aspirin in the same trajectory
through the solvent in absence of the protein. Its principal
sense follows from the fact that experimental techniques
to obtain the protein-ligand affinity (e.g., quenching fluo-
rescence, microcalorimetry) do not take into account the
contribution of the solvent to this out of equilibrium process
(since they analyze equilibrium states).
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Finally, we compared our computational results with
the experimental data available for the affinity constant of
the HSA-ASA complex, obtained by quenching fluorescence
methods [4], showing reasonable agreement.
2. General Procedure
We carried out all molecular dynamics (MD) simulations
using the GROMACS 4.0.1 package [5] in which the
equations of motion are solved using a leap-frog integration
step. We used GROMOS96 (43a1) force field [6] for the
minimization process, as well as for all the MD simulation
steps, and kept all protein bond lengths constrained using
the LINCS algorithm [7]. Water molecules were constrained
using the SETTLE algorithm [8]. For the calculation of long-
range coulombic interactions, we applied the reaction field
method, with a 1.4 nm cut-off radius. Likewise, we calculated
Lennard-Jones interactions within a cut-off radius of 1.4 nm.
For all the simulation runs, we have used a Xeon-based,
dual-processor cluster, running under GNU/Linux, and for
all plots and graphics MS Windows or GNU/Linux, using
the reference VisualMolecular Dynamics package, Swiss PDB
Viewer, or XGrace software [9–11].
As starting configuration we used the human serum
albumin-acetylsalicylic acid complex (PDB ID: 2I30-
Resolution 2.9A˚) that contains five myristic acid molecules
(MYR, C14H28O2) forming part of the albumin structure
[1]. Since the original structure was incomplete, we
reconstructed both the N-terminus and the C-terminus.
Thus, ASP1, ALA2, and LEU585 had to be added ad hoc to
the experimental structure using Swiss PDB Viewer [12],
using standard φ − Ψ angles for the reconstructed peptidic
planes. Moreover, the experimental structure corresponds
to the complex in the post reaction state; that is, the protein
was acetylated in residue LYS199 and the aspirin hydrolyzed.
Thus, we removed the acetyl group from the protein and
reconstructed the modified aspirin.
Having focused on the interaction (and dissociation)
between HSA and its most internal (and more tightly
attached) aspirin ligand, such process will be expected to
occur in absence of the less tightly bonded (and exter-
nal) aspirin ligand. Consequently, the external aspirin was
removed from the initial configuration.
The starting system consisted of a truncated dodecahe-
dral simulation box of dimension parameter d = 12.9702 nm
and a total volume of 1540.65 nm3, containing one HSA
molecule, one ASA molecule, five myristic acid molecules,
and 47.803 water molecules. We used the SPC/E [13] water
model. We aligned the principal axes of the protein and the
box.
We constructed the topologies for aspirin and myristic
acid and added them to GROMOS96 43a1 force field residue
data base, using all the corresponding atom types, charges,
bonds, angles, proper, and improper dihedral angles from
that database. The values used for all atom charges in both
aspirin and myristic acid topologies are summarized in
Tables I(a) and I(b). A detailed schematic representation for
both molecules is additionally provided as supplementary
material (see Supplementary Material available online at
Table 1: Charge distribution used for every atom in the construc-
tion of the Aspirin and Myristic Acid topologies, respectively.
(a)
Atom
number
Atom
Type
Name
Charge
group
Partial
Charge
Mass
1 OM OL 1 −0.635 15.9994
2 C CK 1 0.27 12.011
3 OM OM 1 −0.635 15.9994
4 C CJ 2 0 12.011
5 CR1 CI 2 0 13.019
6 CR1 CH 2 0 13.019
7 CR1 CG 3 0 13.019
8 CR1 CF 3 0 13.019
9 C CE 3 0 12.011
10 OA OD 4 0 15.9994
11 C CB 4 0.38 12.011
12 O OC 4 −0.38 15.9994
13 CH3 CA 5 0 15.035
(b)
Atom
number
Atom
Type
Name
Charge
group
Partial
Charge
Mass
1 OM OB 1 −0.635 15.9994
2 C CA 1 0.27 12.011
3 OM OC 1 −0.635 15.9994
4 CH2 CD 2 0 14.027
5 CH2 CE 2 0 14.027
6 CH2 CF 2 0 14.027
7 CH2 CG 2 0 14.027
8 CH2 CH 2 0 14.027
9 CH2 CI 2 0 14.027
10 CH2 CJ 2 0 14.027
11 CH2 CK 2 0 14.027
12 CH2 CL 2 0 14.027
13 CH2 CM 2 0 14.027
14 CH2 CN 2 0 14.027
15 CH2 CO 2 0 14.027
16 CH3 CP 2 0 15.035
doi:10.1155/2012/642745). As previously validated in recent
literature [14], myristic acid was modeled in the unproto-
nated state and described using parameters derived from the
lipid force field [15]. The carboxylic acid group was based on
the parameters of glutamic acid, which were available from
the corresponding GROMOS96 43a1 force field.
We generated the topology of the total system, with
standard protonation states for all amino acids (pH 7).
In every step, we removed the motion of the center of
mass of the system.
The production system was weakly coupled to a thermal
and hydrostatic bath, in order to work in the isothermal-
isobaric ensemble [16] at T = 300K and P = 1 bar.
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3. Equilibration
We minimized the energy of the system using firstly the
steepest descent method, converging to machine precision.
Secondly, we applied the conjugated gradient method,
converging in less than 20 cycles.
The equilibration of the complete system proved to
be nontrivial, because we had to complete the original
structure and chemically modify it, and we had to perform
a nonstandard series of computational steps to release
the exogenous tensions introduced due to the structural
additions and modifications mentioned previously. Namely,
we performed an MD run in vacuo (in absence of solvent),
using a 0.0001 fs time step and for a total time of 2 ps lightly
coupled to a 100K temperature bath [16], after energy min-
imization in order to let the incorporated residues explore
more stable configurations. During this run, we applied
position restrains on all of the backbone atoms (except for
those incorporated ad hoc). In the same conditions, we
subsequently performed a 10 ps run, using a 0.5 fs time step.
Next and for another 10 ps (using the same time step), we
incorporated the LINCS algorithm to add restrictions in
bond lengths and angles for all molecules belonging to the
complex.
Once the previous procedure was completed, we grad-
ually increased the time step up to 2 fs, likewise increasing
temperature up to the final value of 300K.
At this point, we solvated the system adding 47.803
SPC/E explicit water molecules. In these conditions, we
allowed the solvated system to relax (keeping all solute heavy
atoms restrained to their corresponding crystallographic
positions) during 200 ps, at 300K and 1bar. At the same
temperature and pressure, we subsequently decreased the
position restraints force constants during a 200 ps MD run.
Finally, we released all position restraints and allowed the
system to relax freely for a total simulation time of 20 ns, at
300K and 1bar, after which we considered the system to be
in conformational equilibrium.
The stability of MYR molecules in their binding sites
throughout the total 20 ns of the equilibration run indi-
cates that the conformational equilibrium was correctly
achieved. Together with this, we observed a relative sta-
bility of the HSA backbone (evaluated by the conver-
gence of HSA alpha-carbon root mean square displacement
(RMSD), (see Supplementary Material available online at
doi:10.1155/2012/642745)). These facts are in notable agree-
ment with the widely known role of fatty acids in the
stabilization of a HSA structure [17].
4. AFM Pulling Simulation
Once the system was effectively equilibrated, we performed
30 MD quasistatic runs, applying an external force on
the center of mass of the aspirin, in order to extract this
molecule from its binding site. We coupled all 30 production
simulation runs to a weak temperature and pressure bath of
300K and 1 bar, in order to work in the isothermal-isobaric
ensemble. We randomly generated the initial velocities, using
a unique seed for every production run. The total simulation
time of every production run was 500 ps, with a time step of
2 fs. The constant of the harmonical potential applied at the
center of mass of the aspirin was of k = 1, 000 kJ/(mol·nm2),
and the pulling rate (i.e., the velocity used to move the
free end of the “spring” in the pulling direction) was v =
0.01 nm/ps.
The pulling direction was established as the line connect-
ing the center of mass of the ligand and the center of the
triangle determined by the centers of mass of the R groups
of residues GLU 292, HIS 440, and CYS 448 (i.e., the binding
pocket threshold).
To calculate the work done during this process, we
plotted each component of the force (Fx, Fy , Fz) as a function
of the respective position component of the center of mass
of the acetylsalicylic acid molecule (xASA, yASA, zASA). This is
shown in Figure 1. These graphics show resemblance to the
experimental data obtained from Atomic Force Microscopy
[18].
5. The Jarzynski Relationship
The process of removing a ligand from the site of binding
to its receptor can be done by applying an external force
to the ligand, hence performing a corresponding external
mechanical work. If this work is done quasistatically, the
value obtained for the applied external work is equal to the
free energy variation associated to that process.
When the work done is not quasistatic, the Jarzynski
equality [19, 20] gives a relationship between the variation
in free energy values that describes the state changes in the
system under study, and the correctly averaged ensemble
of the measurements of the external work done to change
that state in a finite time (out of equilibrium). In the case
of a system in contact to an external thermal bath (in the
Canonical ensemble), the correct description of the state
changes of the system is through Helmholtz free energy,
whereas for a system in the isothermal-isobaric ensemble
like the one we are studying, the suitable descriptor of the
equilibrium states is Gibbs free energy.
If the actual distribution is approximated by performing
a finite sample of work performed through an applied
external force, a superior value to the free energy variation
can be obtained from the average work Wa of the finite
sampling, taken as usual:
Wa ≡ 1
Ns
Ns∑
i=1
Wi, (1)
whereNs is the number of measurements andWi the external
work done in the ith process. We can think ofWi as a random
sampling from the distribution ρ(W) that satisfies the so-
called Jarzynski equality at any time ts:
〈
e−W/kBT
〉
≡
∫
Wρ(W , ts)e−W/kBTdW = e−ΔG/kBT , (2)
where T is the temperature, kB the Boltzmann constant, ts
is the time spent to do the described process, and ΔG is the
Gibbs free energy variation.
4 Journal of Biophysics
300
200
100
0
−100
−200
−300
10 11 12 13
xASA (nm)
F x
(p
N
)
(a)
300
200
100
0
−100
−200
−300
109 11
yASA (nm)
F y
(p
N
)
(b)
300
200
100
0
−100
−200
−300
6 5 4 3 2 1
zASA (nm)
F z
(p
N
)
(c)
Figure 1: Example of the components x, y, and z of the applied force, as a function of the respective position component of the acetylsalicylic
acid molecule center of mass (Figures (a), (b), and (c), resp.). The displacement in the z axis was in the negative direction, while for x and y
axes the displacement was in the positive direction.
In this context, the expectation value ofWa, 〈〈Wa〉〉, will
give an upper boundary to the Gibbs free energy variation:
〈〈Wa〉〉 = 〈W〉 ≡
∫
Wρ(W , ts)dW ≥ ΔG. (3)
The Jarzynski equality suggests that Wa is not the correct
quantity to estimate ΔG. A better upper boundary to this
magnitude is given by the so-called finite sampling estimator
of the average from the Jarzynski equality [21]:
Wx ≡ −kBT · ln
⎡
⎣ 1
Ns
Ns∑
i=1
e−Wi/kBT
⎤
⎦. (4)
For Ns = 1, Wx and Wa will be equal and the expectation
value for both will be 〈W〉, and forNs → ∞,Wx will tend to
ΔG, andWa will tend to 〈W〉.
For intermediate values of Ns,
ΔG ≤ 〈〈Wx〉〉 ≤ 〈〈Wa〉〉, (5)
is satisfied.
6. The ViscousWork
The data obtained through nonequilibrium molecular
dynamics pulling of a ligand may reasonably contain a
nondesired contribution due to the work that is necessary to
move a molecule through the solvent under such conditions,
when compared to experimental data obtained in conditions
of equilibrium. Hence, we have undertaken the evaluation of
the relevance of the so-called “viscous work,” in comparison
with the total work.
With this purpose, we prepared a system of the same
shape and dimensions, consisting only of one acetylsalicylic
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Figure 2: Dependence of the value of the magnitude of the mean
force applied on the center of mass of ASA as a function of the
magnitude of the displacement of the spring (pull coordinate), both
for the system in presence (black lines) and absence (red lines) of the
HSA complex. These values represent the mean force at each step,
averaged over the thirty MD runs for both systems. The error bars
show the standard deviation of these mean values (only 80 values
are here presented in order to enhance graphical clearness).
acid molecule in the original position, solely surrounded by
water molecules.
Firstly, we minimized the energy of this system as
described in the previous section and, subsequently, per-
formed short 200 ps stabilization. Once temperature and
pressure reached equilibrium values of 300K and 1 bar, we
coupled the system to a weak thermostatic bath and fixed the
box dimensions. After stabilization, we proceeded as with the
system in presence of HSA, performing 30MD runs with the
same general setup.
7. Results and Discussion
The data presented in Figure 2 corresponds to the mean
value of the magnitude of the force applied on the center
of mass of the acetylsalicylic acid molecule, as a function
of the magnitude of the displacement of the free end of the
ideal spring, both for the system in presence (black lines) and
absence (red lines) of the HSA complex. Error bars show the
standard deviation of those values. In order to obtain greater
graphical clearness, only 80 of these bars are shown. In this
Figure, a marked difference between curves may be observed
up to 2 nm. After this point the error bars cross each other,
finally reaching statistical convergence. The duplication of
this distance (the point of error bar crossing, that is, 4 nm)
was considered as a reasonable criterion for convergence
and was thus chosen as the limit value for production data.
After this point, the magnitude of the applied force becomes
comparable for both systems, which allows us to consider the
acetylsalicylic acid molecule to be out of the binding site.
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Figure 3: Histogram representation of the mechanical work, both
for the system in presence (black bars) and absence (red bars) of the
HSA complex. The continuous lines are the Gaussian distributions
for the corresponding values of standard deviation and mean value
for each histogram population.
In Figure 3, we present a histogram representation of the
distribution of the performed mechanical work, both for the
system in presence (red bars) and absence (black bars) of the
HSA complex. From this study, we may interestingly observe
that the studied samples of both systems are large enough to
clearly distinguish between populations.
The obtained values for Wa and Wx, using (1) and (4),
respectively, are
Wa = (5.0± 0.6)× 10−19 J (usual average),
Wx = (4.0± 0.6)× 10−19 J (Jarzynski′s average).
(6)
From these results we can observe that Wx establishes a
better highest value for ΔG thanWa, in agreement with (5).
Likewise, the average value of the viscous work obtained
using the usual average is
Waviscous = 8± 2× 10−20 J. (7)
And for the finite sampling estimator of the average value
from Jarzynski equality,
Wxviscous = 4± 2× 10−20 J. (8)
For the present case, the obtained value of the viscous
work falls within the order of magnitude of the standard
deviation of the calculated binding work. However, this
may not be the general situation. Additionally, as such
computational methods are refined and sampling capacities
increased, this “viscous work” may reasonably become a
more important source of discrepancy with experimental
observation, therefore rendering its evaluation mandatory.
Taking these into account, the obtained value for Wx
would be
Wxcorrected = (3.6± 0.6)× 10−19 J. (9)
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Regarding the ligand trajectory in this process, we can
distinguish two regions: an interior region that corresponds
to the movement within the binding pocket, where the
pulling direction is univocally determined by the shortest
path between the original position of the ligand and the
binding pocket threshold and a second exterior one.
In the first region, where the unbinding path is confor-
mationally determined, we can assume that the contribution
to the total average work is close to the optimal one,
whereas in the exterior region it is expected that better path
optimization may be achieved.
The separation between both regions was established as
the point in which the center of mass of the ligand crosses
the plane formed by residues GLU 292, HIS 440, and CYS
448 (i.e., the binding pocket threshold).
The first region represents 29.4% of the total trajectory,
with a corresponding pulling coordinate of 1.47 nm, and its
contribution to the corrected work is of (1.9±0.6) × 10−19 J.
The experimental affinity constant of the complex HSA-
aspirin, obtained by Bojko and coworkers from quenching
fluorescence measurements [4], is Ka = 18.79 × 103 M−1.
From this value, we obtain the experimental ΔG as
ΔG = kBT lnKa = 4.07× 10−20 J. (10)
The upper boundary obtained using the finite sampling
estimator of the average work gives a better value than that
obtained from the usual average work. Albeit more recent
comments on Jarzynski’s work [22], his response is clear and
categorical [23], and this result comes in line with what he
classically proposes.
8. Conclusion
In the present study, we have succeeded in reconstructing,
stabilizing, and equilibrating a protein ligand complex which
proceeded from incomplete data provided from experiment.
This achieved equilibrium state enabled us to study the
HSA-ASA-MYR complex through nonequilibrium molecu-
lar dynamics, in near quasistatic conditions. The fact that
complex biological structures, that are not totally resolved
through experiment, may be eligible targets for molecular
dynamic studies reinforces the importance and potentiality
of this technique.
We have likewise obtained an average upper boundary
for the Gibbs free energy of binding of the HSA-ASA
complex that is less than one order of magnitude above the
experimental value.
As regards the assessment of the relevance of the viscous
work, the value obtained is low compared to the upper
boundary for the Gibbs free energy difference of the HSA-
ASA complex. Nevertheless, its difference with the experi-
mental free energy of binding is not negligible and should
therefore be generally taken into account in such studies.
Moreover, the relevance of this effect, and the need for its
correct evaluation may reasonably increase as computational
methods are refined and sampling capacities increased.
Finally, the promising level of agreement of the data
presented in this study with that available experimentally
calls for further development of such studies as well as
encourages the analysis of other similar systems.
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